Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.

@article{Khong1999UltrasoundCA,
  title={Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.},
  author={Pek-Lan Khong and Ming Tak Chau and Sheung Tat Fan and Lilian L Y Leong},
  journal={Australasian radiology},
  year={1999},
  volume={43 2},
  pages={156-9}
}
In a phase IIIb clinical trial of the ultrasound contrast agent Levovist (Schering AG, Berlin, Germany), the role of Levovist in the management of patients with clinically suspected hepatocellular carcinoma (HCC) was evaluated and its efficacy was assessed. The assessment included the duration of diagnostically usable Doppler signal enhancement, and safety… CONTINUE READING